Survival improvements in major cancers: Trends and disparities in the United States, 2000–2019
International Journal of Cancer · 01.05.2026 · 158 (9) · 2329-2338
DOI: 10.1002/ijc.70262 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 25.11.2025. Verfasst von Yaxiong Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Neoplasms, Healthcare Disparities. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of China.
Abstract (Originalsprache)
Advances in cancer management have improved oncologic outcomes, but the extent of these improvements and disparities across demographic and socioeconomic groups over the past two decades remains unclear. We identified patients diagnosed with primary cancer at eight sites (lung and bronchus, liver and intrahepatic bile ducts [IHBD], esophagus, colon, kidney, pancreas, rectum, and stomach) between 2000 and 2019 from the Surveillance, Epidemiology, and End Results (SEER)‐17 database. Kaplan–Meier curves were used to evaluate cancer‐specific survival (CSS) across different diagnostic periods, and Cox proportional hazards models were employed to adjust for confounding factors. We found that CSS for eight cancers improved significantly between 2000 and 2019, but the extent of improvement varied by population characteristics. Elderly patients, unmarried individuals, those with low income, and rural residents showed poorer relative CSS improvement across all eight cancers. Relative CSS improvement differences by sex were present across the eight cancers but remained small. Black patients exhibited less relative CSS improvement than White patients only in pancreatic cancer. Absolute 5‐year CSS differences by race (White vs. Black) decreased in six cancers except pancreatic and gastric cancers. In summary, the extent of improvement in CSS for the eight cancers varied by demographic characteristics between 2000 and 2019. Absolute survival differences by age, marital status, income, and place of residence widened for most cancers, while racial differences (White vs. Black) narrowed for most cancers. This provides potential recommendations for further adjustments in medical resources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Jianzhong Ai
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of China
- Natural Science Foundation of Sichuan
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Tang, Y., Yi, X., Han, Z., Li, X., Zheng, X., & Ai, J. (2026). Survival improvements in major cancers: Trends and disparities in the United States, 2000–2019. International Journal of Cancer, 158(9), 2329-2338. https://doi.org/10.1002/ijc.70262
Vancouver
Tang Y, Yi X, Han Z, Li X, Zheng X, Ai J. Survival improvements in major cancers: Trends and disparities in the United States, 2000–2019. International Journal of Cancer. 2026;158(9):2329-2338. doi:10.1002/ijc.70262
BibTeX
@article{Tang2026,
author = {Tang, Yaxiong and Yi, Xianyanling and Han, Zeyu and Li, Xuanji and Zheng, Xiaonan and Ai, Jianzhong},
title = {Survival improvements in major cancers: Trends and disparities in the United States, 2000–2019},
journal = {International Journal of Cancer},
year = {2026},
volume = {158},
number = {9},
pages = {2329--2338},
doi = {10.1002/ijc.70262}
}
EUVIMED